tiprankstipranks
Trending News
More News >
Glenmark Pharmaceuticals Limited (IN:GLENMARK)
:GLENMARK
India Market

Glenmark Pharmaceuticals Limited (GLENMARK) Income Statement

Compare
4 Followers

Glenmark Pharmaceuticals Limited Income Statement

Last quarter (Q1 2026), Glenmark Pharmaceuticals Limited's total revenue was ₹32.64B, an increase of 0.62% from the same quarter last year. In Q1, Glenmark Pharmaceuticals Limited's net income was ₹468.71M. See Glenmark Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 133.63B₹ 126.45B₹ 116.56B₹ 123.05B₹ 109.44B
Gross Profit
₹ 88.38B₹ 80.66B₹ 72.45B₹ 77.57B₹ 70.97B
Operating Expenses
₹ 46.55B₹ 46.72B₹ 44.33B₹ 41.96B₹ 41.29B
Depreciation and Amortization
₹ 2.61B₹ 3.84B₹ 2.91B₹ 723.93M₹ 2.29B
EBITDA
₹ 21.68B₹ 18.30B₹ 14.29B₹ 19.12B₹ 19.45B
Operating Income
₹ 41.84B₹ 33.94B₹ 28.11B₹ 35.60B₹ 29.68B
Other Income/Expenses
₹ -27.85B₹ -33.58B₹ -25.72B₹ -21.19B₹ -15.86B
Pretax Income
₹ 13.99B₹ 364.95M₹ 2.40B₹ 14.41B₹ 13.82B
Net Income
₹ 10.47B₹ -15.02B₹ 2.97B₹ 9.42B₹ 9.70B
Per Share Metrics
Basic EPS
₹ 37.11₹ -67.30₹ -6.01₹ 33.37₹ 34.38
Diluted EPS
₹ 37.11₹ -67.30₹ -6.01₹ 33.37₹ 34.38
Weighted Average Shares Outstanding
282.19M 282.17M 282.17M 282.20M 282.17M
Weighted Average Shares Outstanding (Diluted)
282.21M 282.18M 282.17M 282.17M 282.17M
Currency in INR

Glenmark Pharmaceuticals Limited Earnings and Revenue History